No Data
No Data
No Data
Debon Securities: Pet food is in a high-speed development stage of e-commerce, and the process of domestic substitutes is accelerating. The industry leaders are seizing overseas brand shares.
Compared to beauty products, pet food is easier to defend but harder to attack due to the heavier investment in research and development, capital expenditures for factories and supply chains, and higher consumer trust.
Xinruipeng voluntarily withdrew its application for IPO in the United States and will restart the listing process at a more appropriate time.
On June 8th, Gelunhui reported that New Ruipeng Pet Medical Group (RPET.US), an innovative and entrepreneurial enterprise whose main business is chain pet medical care, withdrew its IPO plan in the United States. The company initially filed an application in January 2023 and planned to raise $100 million. New Ruipeng stated that the decision to voluntarily withdraw the IPO application materials was the result of comprehensive and prudent consideration of the market environment and the company's overall development strategy. Currently, the company's operations continue to improve. Next, the company will continue to closely monitor the global capital market trends and select a more suitable timing to resume the listing process.
Pet hospital operator New Rui Peng (RPET.US) withdraws US IPO, originally planned to raise $100 million.
Chinese pet hospital operator New Ray Peng Group withdrew its IPO plan on Thursday, originally submitted in January 2023, with a planned fundraising of $100 million.
Chinese Pet Services Provider New Ruipeng Pulls US IPO
Express News | According to documents from the US Securities and Exchange Commission, New Ruipeng Pet Group Co., Ltd. has applied to withdraw its plan for initial public offering (IPO) in the United States.
What is the value of XinRuipeng (RPET.US), a super ecological platform focused on pets?
As a star pet racetrack company, Xinruipeng has received market attention for a long time, and has been pushed into the “spotlight” since submitting the prospectus. And why does Xinruipeng continue to influence the market's eyes? Where should investors start to understand and understand the value of their investments? The author believes that Xinruipeng's business segment contains important investment leads. As we all know, the Chinese pet market is on the rise and has huge potential. It seems that it is already a new consumer force that cannot be ignored, and a new term has also been born — “its economy.” Pet medicine is a high-value and advantageous field in its economy. It corresponds to more room for penetration, higher spending amounts, and higher amounts
No Data
No Data